How Johnson & Johnson Makes Most of Its Money
As you might expect, Johnson & Johnson (NYSE: JNJ) makes a lot of money. Last year, the healthcare giant generated revenue totaling nearly $72 billion. Over the past decade, J&J raked in over $668 billion. To put that amount into perspective, consider that a stack of that many $1 bills would reach more than 45,000 miles into the sky -- close to one-fifth the distance to the moon.
But where does all that revenue come from? Here's how Johnson & Johnson makes most of its money.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Aktie
221,55 €
0,14 %
Johnson & Johnson als klarer Gewinner: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Community-Kursziel von 228 € für Johnson & Johnson deutet auf ein leicht positives Wachstumspotenzial gegenüber 221.55 € hin.
